Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27068858

Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2016 May
First author
Mir O

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 May;17(5):549-50. doi: 10.1016/S1470-2045(16)00101-7.
    note
    Source null
    related pmid
    27068859
    relationship
    Comment in
  2. citation
    Transl Gastroenterol Hepatol. 2016 Nov 29;1:86. doi: 10.21037/tgh.2016.11.01.
    note
    Source null
    related pmid
    28138651
    relationship
    Comment in

Authors and identifiers

  1. name
    Mir O
    type
    Author
  2. name
    Cropet C
    type
    Author
  3. name
    Toulmonde M
    type
    Author
  4. name
    Cesne AL
    type
    Author
  5. name
    Molimard M
    type
    Author
  6. name
    Bompas E
    type
    Author
  7. name
    Cassier P
    type
    Author
  8. name
    Ray-Coquard I
    type
    Author
  9. name
    Rios M
    type
    Author
  10. name
    Adenis A
    type
    Author
  11. name
    Italiano A
    type
    Author
  12. name
    Bouché O
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mir O
    type
    Author
  2. name
    Cropet C
    type
    Author
  3. name
    Toulmonde M
    type
    Author
  4. name
    Cesne AL
    type
    Author
  5. name
    Molimard M
    type
    Author
  6. name
    Bompas E
    type
    Author
  7. name
    Cassier P
    type
    Author
  8. name
    Ray-Coquard I
    type
    Author
  9. name
    Rios M
    type
    Author
  10. name
    Adenis A
    type
    Author
  11. name
    Italiano A
    type
    Author
  12. name
    Bouché O
    type
    Author
bibliography ids
  1. nci-bib-df3b4815c28031df78a54f51
book metadata
content sha256
c5978d2c46859c01a0b311331813a10f58c849e6c2273e8b76f778a8e824e4a6
document type
citation
dois
  1. 10.1016/S1470-2045(16)00075-9
electronic publication date
display
2016 Apr 5
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27068858
immutable id
pubmed:27068858@c5978d2c46859c01a0b311331813a10f58c849e6c2273e8b76f778a8e824e4a6
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
632-41
volume
17
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2016 May;17(5):549-50. doi: 10.1016/S1470-2045(16)00101-7.
    note
    Source null
    related pmid
    27068859
    relationship
    Comment in
  2. citation
    Transl Gastroenterol Hepatol. 2016 Nov 29;1:86. doi: 10.21037/tgh.2016.11.01.
    note
    Source null
    related pmid
    28138651
    relationship
    Comment in
outcomes validated
false
pmid
27068858
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
1855b6dd05e41bfc36215bac715e2f0ffc32cc2b95aefce563c0c6f6cd0bb3af
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 May
precision
month
year
2016
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27068858/
title
Pazopanib plus best supportive care versus best supportive care alone in advanced gastrointestinal stromal tumours resistant to imatinib and sunitinib (PAZOGIST): a randomised, multicentre, open-label phase 2 trial.

Preserved source evidence · Not medical advice